Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ana Maria

Ana Maria Benitez Sanchez, Duren DE

Patent application numberDescriptionPublished
20120114481WIND TURBINE AND CONTROL METHOD OF A WIND TURBINE - A wind turbine includes a rotor and a main shaft, wherein the main shaft is coupled to the rotor for transforming wind energy into kinetic energy of rotation of the main shaft. The main shaft is mechanically coupled to a main generator of the wind turbine, wherein the main generator transforms kinetic energy of rotation into electrical energy. Further, a brake system is provided which has an energy recovery arrangement for recovering at least part of the kinetic energy of the rotation of the main shaft when a rotational speed of the rotor is reduced by the brake system.05-10-2012

Ana Maria Burguiere, Clamart FR

Patent application numberDescriptionPublished
20110065089NOVEL STRAIN OF SARS-ASSOCIATED CORONAVIRUS AND APPLICATIONS THEREOF - The invention relates to a novel strain of severe acute respiratory syndrome (SARS)-associated coronavirus, resulting from a sample collected in Hanoi (Vietnam), reference number 031589, nucleic acid molecules originating from the genome of same, proteins and peptides coded by said nucleic acid molecules and, more specifically, protein N and the applications thereof, for example, as diagnostic reagents and/or as a vaccine.03-17-2011
20120082693USE OF PROTEINS AND PEPTIDES ENCODED BY THE GENOME OF A NOVEL SARS-ASSOCIATED CORONAVIRUS STRAIN - The invention relates to the use of proteins and peptides coded by the genome of the isolated or purified strain of severe acute respiratory syndrome (SARS)-associated coronavirus, resulting from sample reference number 031589 and, in particular, to the use of protein S and the derivative antibodies thereof as diagnostic reagents and as a vaccine.04-05-2012

Patent applications by Ana Maria Burguiere, Clamart FR

Ana Maria Cano Sierra, Heidelberg DE

Patent application numberDescriptionPublished
20110112230FORMALDEHYDE SCAVENGERS - The invention relates to new formaldehyde scavengers, a process for reducing the amount of formaldehyde by adding these scavengers and their use.05-12-2011
20110318586Innovative flexible packaging forms, method for producing them and use thereof - The invention relates to innovative flexible packaging forms comprising at least 2 different layers of material joined by means of one or more adhesive layers, at least one of these adhesive layers comprising a carbodiimide or a mixture of two or more carbodiimides, to a method for producing them and to the use thereof.12-29-2011
20120071595Novel aqueous resorcinol-formaldehyde-latex dispersions, adhesion-improved fibres, processes for production thereof and use thereof - The present invention relates to novel aqueous resorcinol-formaldehyde-latex dispersion, to adhesion-improved fibres, to processes for production thereof, and to use thereof for improving adhesion in tyres.03-22-2012
20120100290Novel bonding agents based on carbodiimides, aqueous resorcinol-formaldehyde-latex dispersions comprising bonding agent, adhesion-improved fibres, processes for production thereof and use thereof - The present invention relates to novel bonding agents based on carbodiimides, to aqueous resorcinol-formaldehyde-latex dispersion comprising bonding agent, to adhesion-improved fibres, to processes for production thereof, and to use thereof for improving adhesion in tyres.04-26-2012
20120101200Innovative long-lasting biobased plastics based on polyhydroxyalkanoate, a method for producing them and use thereof - The present invention provides innovative long-lasting and hydrolysis-stable biobased plastics based on polyhydroxyalkanoate (PHA), a method for producing them and their use.04-26-2012

Ana Maria Cardells, Barcelona ES

Patent application numberDescriptionPublished
20090135217SELECTING PRINTING MASKS OPTIMIZED FOR LINE FEATURES AND AREA FILL FEATURES OF IMAGE DATA - For each totally black pixel of image data to be printed using a fluid-ejection printing device, it is determined whether the pixel is part of a line feature or an area fill feature of the image data. Where the pixel is part of a line feature, a first printing mask selected that is optimized for printing line features. Where the pixel is part of an area fill feature, a second printing mask is selected that is optimized for printing area fill features. Each mask specifies a number of fluid droplets to be printed and positions where the fluid droplets are to be printed. The selected mask is applied to the pixel. The pixel is printed using the mask that has been applied. The fluid-ejection printing device prints the pixel by ejecting the number of fluid droplets specified by the mask at the positions specified by the mask.05-28-2009
20120076514METHOD AND SYSTEM TO TRACK UNUSED MEDIA - In one embodiment, data is discerned, the data indicative of a first quantity of unused media contained within a roll. Prior to a plot being printed on the roll, a second quantity of unused media expected to be in the roll after the plot is printed is discerned using the data. Printing of a machine-readable marking on the roll, along with the plot, is caused, the marking being indicative of the second quantity.03-29-2012

Patent applications by Ana Maria Cardells, Barcelona ES

Ana Maria Garcia Collazo, Stockholm SE

Patent application numberDescriptionPublished
20080221210Thyroid Receptor Agonists - The invention provides compounds of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides the use of such compounds in the treatment or prophylaxis of a condition mediated by a thyroid receptor. Formula (I), wherein R09-11-2008

Ana Maria Garcia Collazo, Madrid ES

Patent application numberDescriptionPublished
20090318514Novel Pharmaceutical Compositions - The invention provides the use of compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, for the manufacture of a medicament for the treatment or prophylaxis of a condition that may be treated with a thyroid receptor agonist or partial agonist wherein R12-24-2009
20100004271HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR - The invention provides Compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, wherein R01-07-2010
20110046127Imidazopyridazines for Use as Protein Kinase Inhibitors - There is provided compounds of formula (I): wherein Z, M, R02-24-2011
20110190289Imidazolothiadiazoles for Use as Protein Kinase Inhibitors - There is provided compounds of formula (I), wherein Z, M, R08-04-2011

Patent applications by Ana Maria Garcia Collazo, Madrid ES

Ana Maria Henao-Restrepo, Geneva CH

Patent application numberDescriptionPublished
20100074911VACCINE NEBULIZERS - The invention provides a method of selecting or optimising a nebuliser device to be used to deliver a vaccine comprising selecting a nebuliser capable of producing a plurality of vaccine particles having the following particle droplet size distribution: 03-25-2010

Ana Maria Lopez Nieto, Madrid ES

Patent application numberDescriptionPublished
20090196225DEVICES AND METHOD FOR GUARANTEEING QUALITY OF SERVICE PER SERVICE DATA FLOW THROUGH THE BEARER LAYER - In scenarios where the quality of service is negotiated through a signalling layer whereas the services are actually carried through a bearer layer, application functions at the signalling layer are not always aware of how quality of service is individually accomplished at the bearer layer on a service basis. The invention provides a method and devices whereby events are detected on a service data flow basis at a detection device in the bearer layer and notified towards an application device in the signalling layer via a control device between the signalling and the bearer layer. The list of events to be notified is obtainable at the control device from the application device and is included in Quality of Service related rules, along with service data flow filters. This Quality of Service related rules are provided to the detection device for inspecting individual service data flows in order to detect and notify the indicated events.08-06-2009
20090215454Method and Apparatus for use in a Communications Network - A method and apparatus for registering a mobile node such as a User Equipment (UE) of a UMTS telecommunications network with a subsystem of the network such as an IP Multimedia Subsystem (IMS). A Policy and Charging Rules Function (PCRF) node provides policy and charging rules, and a Gateway GPRS Support Node (GGSN) enforces the rules for traffic flows. The UE sends a registration request to the GGSN, which selects a PCRF. When a Proxy Call Session Control Function (P-CSCF) receives the registration request, the P-CSCF selects a candidate PCRF and validates the selection. If the candidate PCRF is the PCRF selected by the GGSN, the registration is successful. If not, the P-CSCF may select another PCRF and repeat the validation process.08-27-2009
20100217877Method and System for Enabling Access Policy and Charging Control - The present invention relates in general to a method and apparatus concerning access policy and charging control. In particular it relates to enhanced service information for access policy and charging control. A media stream management of a service session between a first and a second electronic communication device comprise obtaining identity address data related to the first electronic communication device step, obtaining policy information associated with the second electronic communication device step, and performing a media stream management control step involving the identity address data related to the first electronic communication device and the policy information related to the second electronic communication device such that media streams between the first electronic communication device and the second electronic communication device can be controlled.08-26-2010
20110208853POLICY AND CHARGING CONTROL METHOD, SERVERS AND COMPUTER PROGRAMS THEREFOR - A policy and charging control method includes creating by a policy and charging rules function (PCRF), first policy and charging control (PCC) rules at establishment of a user plane session associated with the UE. The first PCC rules are installed at a policy and charging enforcement function (PCEF) and the service is initiated in accordance with these rules. During the lifetime of the user plane session, a quality-of-service (QoS) change request is transmitted by the UE upon activation of a user interface command. The PCRF creates second PCC rules based on the request, and installs them at the PCEF by replacing the first PCC rules by the second PCC rules. The service is continued in accordance with the second PCC rules. PCRF and PCEF servers as well as computer programs are also defined.08-25-2011
20110235510DEVICES AND METHOD FOR GUARANTEEING QUALITY OF SERVICE PER SERVICE DATA FLOW THROUGH THE BEARER LAYER - In scenarios where the quality of service is negotiated through a signalling layer whereas the services are actually carried through a bearer layer, application functions at the signalling layer are not always aware of how quality of service is individually accomplished at the bearer layer on a service basis. The invention provides a method and devices whereby events are detected on a service data flow basis at a detection device in the bearer layer and notified towards an application device in the signalling layer via a control device between the signalling and the bearer layer. The list of events to be notified is obtainable at the control device from the application device and is included in Quality of Service related rules, along with service data flow filters. This Quality of Service related rules are provided to the detection device for inspecting individual service data flows in order to detect and notify the indicated events.09-29-2011
20120023246GROUP SESSION MANAGEMENT FOR POLICY CONTROL - At present some situations occur where a policy control at individual user level is not enough. For example, where a plurality of users surpasses a load limit in a certain location area, which could imply a risk of network congestion, policy control decisions in conventional architectures have to be made by submitting corresponding orders for each user affected by the decision, thus resulting in a higher signalling and processing load. To overcome these drawbacks, the present specification provides for new network entities and method to monitor and control a plurality of users, as dynamically determined according to different selection criteria, in order to compile users-related aggregated reports, to establish dynamic group of users whom specific policy control rules can be applied, and to map orders and information between group and user level.01-26-2012
20120059943Establishing a Communication Session - According to a first aspect of the present invention there is provided a method of operating an IP Multimedia Subsystem Application Server to facilitate a communication session between a first user and a second user at a required Quality of Service. The method comprises receiving a notification that a Policy and Charging Rules function associated with the first user has not authorised said required Quality of Service (B03-08-2012
20120059944ESTABLISHING A COMMUNICATION SESSION - According to a first aspect of the present invention there is provided a method of facilitating a communication session between a user terminal and an Application Function over an IP Connectivity Access Network. The method comprises, at a Policy and Charging Rules Function, receiving information relating to the session from the Application Function (B3), determining one or more Policy and Charging Control rules for the session including deriving a Quality of Service authorised for the session, and sending the Policy and Charging Control rules, including the authorised Quality of Service, to a Policy and Charging Enforcement Function (B5). At the Policy and Charging Enforcement Function, installing the one or more Policy and Charging Control rules including the aurhtorised Quality of Service for the session, and, if it is determined that the authorised Quality of Service cannot be achieved due to a limitation on a Quality of Service available in the Access Network, then reporting this to the Policy and Charging Rules Function and including the available Quality of Service (B8). At the Policy and Charging Rules Function, receiving the report from the Policy and Charging Enforcement Function, including the available Quality of Service, and using the available Quality of Service to determine whether and/or how to maintain the session.03-08-2012
20120064878POLICY AND CHARGING CONTROL METHOD, NETWORK ENTITIES, COMMUNICATION SYSTEM AND COMPUTER PROGRAM THEREFOR - It is provided a policy and charging control method carried out in a communication network. The communication network comprises a first network entity (03-15-2012

Patent applications by Ana Maria Lopez Nieto, Madrid ES

Ana Maria Otero Casal, Santiago De Compostela ES

Patent application numberDescriptionPublished
20110195051USE OF BACTERIA OF THE GENUS TENACIBACULUM FOR QUORUM QUENCHING - Use of bacterial cells of the genus 08-11-2011

Ana Maria Pereira Gomes, Porto PT

Patent application numberDescriptionPublished
20100028489PRE-FERMENTED SYMBIOTIC MATRIX BASED ON A CEREAL SUSPENSION WITH ENCAPSULATED PROBIOTICS, MANUFACTURE PROCESS AND CORRESPONDING UTILIZATION - The present invention is about a pre-fermented symbiotic matrix based on a cereal suspension, preferably oat, containing encapsulated probiotics and prebiotics, the manufacturing process and the corresponding utilization. The present invention's object is the development of a cereal symbiotic matrix, preferably from oat, pre-fermented with encapsulated probiotics and free and/or encapsulated prebiotics, with the aim of complementing the actual functional food market and solving problems inherent to the reduced shelf-life period of such foods due to loss of probiotic viability to values below the minimum limits needed in order to promote biological activity. Furthermore, the present invention's object is to improve the fermentative process conditions at different levels, namely fermentation time reduction in order to reduce energy consumption during the process and the risk of contamination reduction as well as promote long term microbial stability maintenance. The pre-fermented symbiotic matrix is designed, in particular, for those cases where intolerance and/or allergy to dairy products occur, yet it is further applicable to the pharmaceutical, cosmetic and preferably food industries, including pet food.02-04-2010

Ana Maria Perez De Rozas Ruiz De Guana, Barcelona ES

Patent application numberDescriptionPublished
20110104205HETEROLOGOUS PROTECTION AGAINST PASTEURELLA MULTOCIDA PROVIDED BY P. MULTOCIDA FUR CELLS AND THE OUTER-MEMBRANE PROTEIN EXTRACTS THEREOF - The invention relates to 05-05-2011

Ana Maria Pérez Vendrell, Maspujols (tarragona) ES

Patent application numberDescriptionPublished
20110086016Enzymatic pre-mixture against Gram negative bacteria colonization in the animal intestinal tract - The invention provides pre-mixture for animal feeding comprising: (a) a polymer or a mixture of polymers, with a content in mannose comprised between 10% and 100%; (b) β-mannanase enzyme; and (c) an anti-binding agent; wherein the anti-binding agent has an absorptive capacity higher than 20%, and a bulk density which is comprised between 0.10 and 2.70 g/cm04-14-2011

Ana Maria Pérez Vendrell, Maspujols (tarragona) ES

Patent application numberDescriptionPublished
20110086016Enzymatic pre-mixture against Gram negative bacteria colonization in the animal intestinal tract - The invention provides pre-mixture for animal feeding comprising: (a) a polymer or a mixture of polymers, with a content in mannose comprised between 10% and 100%; (b) β-mannanase enzyme; and (c) an anti-binding agent; wherein the anti-binding agent has an absorptive capacity higher than 20%, and a bulk density which is comprised between 0.10 and 2.70 g/cm04-14-2011

Ana Maria Sandino, Las Condes CL

Patent application numberDescriptionPublished
20100204290PROCEDURE FOR OPERATING A PARTICLE FILTER ARRANGED IN AN EXHAUST FUME AREA OF A BRENNKRAFTMASCHINE AND DEVICE TO EXECUTE THE PROCEDURE - A method of increasing the survival of animals and aquatic species susceptible to birnavirus infection by treating them before, during and/or after bimavirus exposure, with a chemical compound capable of inhibiting viral replication. A method of treating aquatic species to increase their survival in the presence of a virus, particularly an aquatic bimavirus, and to increase the yield of farmed fish susceptible to viral infection. The present invention provides methods for increasing survival of virally-exposed aquatic animals by administering therapeutically effective amounts of isoxazol compounds to aquatic animals susceptible to bimavirus infection and/or IPNV infection, particularly in fish such as salmonoid species, which are easily exposed to IPNV. The present invention also provides methods for increasing survival of virally-exposed animals by administering therapeutically effective amounts of isoxazol compounds to farmed animals susceptible to bimavirus infection and/or IBDV infection, particularly in poultry such as chickens, which are exposed to IBDV.08-12-2010

Ana Maria Schor, Dundee GB

Patent application numberDescriptionPublished
20090221561Cell Migration Modulating Compounds - The described invention relates to compounds which modulate cell migration, and find use in, for example, wound healing, cancer progression and angiogenesis.09-03-2009

Ana Maria Serrano Mollar, Barcelona ES

Patent application numberDescriptionPublished
20090220467USE OF TYPE II PNEUMOCYTES IN THE TREATMENT OF PULMONARY DISEASES ASSOCIATED WITH PULMONARY FIBROSIS - It describes the use of type II pneumocytes as inhibitory agents of fibroblast proliferation, for which reason they can be used in the preparation of a drug for the treatment of lung diseases which present with pulmonary fibrosis.09-03-2009

Ana Maria Staack Reis Machado, Lisboa PT

Patent application numberDescriptionPublished
200802798082,3,4,5-Tetrahydroxy-6-Sulfooxy Hexanoic Acid, Pharmaceutically Acceptable Salts and Equilibrium Forms Thereof, Processes for Their Preparation, Pharmaceutical Compositions Comprising Such Compounds and Their Medical Use - The invention relates to novel compounds of general formula I wherein M represents hydrogen, or a metallic cation, preferably an alkaline metal, or alkaline-earth metal, and n is equal to 1, 2 or 3. The present invention also comprises compounds of general formula I in their equilibrium forms, including lactonic forms, their enantiomers in pure form, or in an enriched form in one of the optical isomers, racemic mixtures, diastereomers and solvates thereof. The present invention further relates to processes for the preparation of compounds of general formula I, to pharmaceutical compositions comprising compounds of general formula I as only active ingredient, or in association with other active ingredients. Another aspect of the invention is the use of compounds of general formula I for the treatment of dyslipidemia, associated, or not, to other metabolic disorders, such as glucose intolerance syndrome and type 1 or 2 diabetes mellitus, by means of isolated administration or combined with other substances.11-13-2008

Ana Maria Torrent Gibert, Barcelona ES

Patent application numberDescriptionPublished
20100129331DISACCHRIDES FOR THE TREATMENT OF TENDONS, LIGAMENTS, AND BONES - The present invention relates to the use of a series of disaccharides, as well as of compositions containing them, for the preparation of a medicament for the treatment or prevention of a tendon, ligament or bone disease, disorder or injury. The present invention also relates to the new compositions comprising a disaccharide in combination with inulin polysulphate, a glycosamino-glycan, a growth factor or cells. The glycosaminoglycan is preferably chondroitin sulphate or hyaluronic acid and the growth fact is IFG-1.05-27-2010
20100286086COMPOSITION FOR THE TREATMENT OF OSTEOARTHRITIS - The present invention relates to compositions comprising chondroitin sulphate and mannosamine or a derivative thereof. The mannosamine derivative is preferably N-acetylmannosamine. The compositions may comprise glucosamine. Said compositions are useful in the treatment or prevention of degenerative joint diseases, preferably of osteoarthritis, in the treatment or prevention of tendon or ligament diseases, disorders or injuries and of immune system diseases, preferably of rheumatoid arthritis.11-11-2010

Ana Maria Torres Redondo, Madrid ES

Patent application numberDescriptionPublished
20110165264USE OF CILASTATIN TO REDUCE NEPHROTATOXICITY OF VARIOUS COMPOUNDS - Use of cilastatin to reduce the nephrotoxicity of different compounds. The invention refers to use of cilastatin to prepare a medicinal product to reduce the nephrotoxicity of a nephrotoxic compound that enters the cells of the proximal tubule through cholesterol rafts. The invention is based on the discovery that a great number of nephrotoxic compounds, including drugs, enter the cells of the proximal tubule through the cholesterol rafts, and that cilastatin is able to interfere with this transport mechanism, decreasing the nephrotoxicity of such compounds to a variable extent. The nephroprotective effect is common to compounds of different chemical nature and solubility and is specific for the kidney, causing no interference with the effects of nephrotoxic drugs having their targets in other organs. Therefore, administration of cilastatin allows for decreasing the nephrotoxic effects of different drugs without reducing their therapeutic effects.07-07-2011

Ana Maria Vazquez Lopez, C. Habana CU

Patent application numberDescriptionPublished
20120121605ANTI SULFATIDES AND ANTI SUFATED PROTEOGLYCANS ANTIBODIES AND THEIR USE - The present invention relates to the biotechnology and particularly with new products for use in human health.05-17-2012

Ana Maria Vazquez Molini, Albacete ES

Patent application numberDescriptionPublished
20080206739Analysis Method for Pesticide Residues in Plant Samples - The invention relates to an analysis method for pesticide residues in plants. The method uses the interface device for the direct coupling of liquid chromatography and gas chromatography, called the TOTAD (Through Oven Transfer Adsorption Desorption) interface in scientific literature. The method only requires an extraction step prior to the chromatographic analysis. The pesticides are extracted from the sample with an organic solvent. Extract volumes that are much larger than those usually used are directly injected into the gas chromatograph, without needing any prior extract cleaning or concentration step. The TOTAD interface allows injecting extract volumes that are much larger than those normally injected into the gas chromatograph.08-28-2008
20080272044Interphase Injector Device For the Direct Coupling of Liquid Chromatography and Gas Chromatography - The invention relates to an interface injector device for the direct coupling of liquid chromatography and gas chromatography, comprising an outer body (11-06-2008
20090217735Gas Chromatography System and Method - The invention relates to a gas chromatography system for the direct coupling of liquid chromatography and gas chromatography or for the introduction of large sample volumes, which is configured to operate selectively in a retention mode. The inventive system includes a tube (09-03-2009

Ana Maria Zarraga, Valdivia CL

Patent application numberDescriptionPublished
20100304371COMPOSITIONS AND METHODS FOR DETECTING MYCOBACTERIA - The present invention features compositions and methods that can be used to analyze samples for the presence of 12-02-2010

Ana María García Osta, Pamplona ES

Patent application numberDescriptionPublished
20110027251NOVEL USES FOR 4-PHENYLBUTYRATE (4PBA) AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS - Novel uses for 4-phenylbutyrate (4PBA) and its pharmaceutically acceptable salts02-03-2011

Ana María Hernández González, Alicante ES

Patent application numberDescriptionPublished
20100102991PEDESTRIAN CROSSING WITH PRESENCE DETECTOR AND WARNING - Pedestrian crossing with presence detector and warning, characterised in that it constitutes an independent and transportable constructive element, easy to assemble and dismantle, with low maintenance cost, equipped with presence detectors, warning devices, power supply system, accumulators and electronic devices (circuitry, etc.), which detects pedestrians, vehicles, or both, in a crossing zone, and alerts both drivers and pedestrians themselves, of their respective presence on said crossing, or in the proximity thereto, and provides greater road safety, reduces the risk of accidents for pedestrians due to inclement weather, reduces acoustic contamination and gives greater versatility to the use of public roads, also has uses in fixed pedestrian crossings in the form of total or partial introduction of the different elements constituting the invention or in the form, for example, of total or partial shelters for fixed crossings incorporating said elements.04-29-2010

Ana María Procopiuk, Pergamino AR

Patent application numberDescriptionPublished
20100325750Major QTLS Conferring Resistance Of Corn To Fijivirus - The invention relates to methods and compositions for identifying maize plants that have newly conferred resistance or enhanced resistance to, or are susceptible to, a Fijivirus, particularly Mal de Río Cuarto Virus (MRCV) and/or Maize Rough Dwarf Virus (MRDV). The methods use molecular genetic markers to identify, select and/or construct resistant plants or identify and counter-select susceptible plants. Maize plants that display newly conferred resistance or enhanced resistance to a Fijivirus that are generated by the methods of the invention are also a feature of the invention.12-23-2010